Trial Profile
Efficacy and Safety of Co-administration of Omacor Plus Atorvastatin Compared With Atorvastatin Monotherapy in Patients With Type Ⅱb Dyslipidemia: a Multicenter, Double-blind, Randomized, Active-controlled, Parallel, Phase Ⅲ Study
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Omega-3-acid ethyl esters (Primary) ; Atorvastatin
- Indications Hyperlipidaemia
- Focus Registrational; Therapeutic Use
- Sponsors Kuhnil Pharmaceutical Company
- 22 Jan 2014 New trial record